Zentalis Pharmaceuticals Llc (ZNTL) — Cash Flow-to-Debt Ratio
Zentalis Pharmaceuticals Llc (ZNTL) has a Cash Flow-to-Debt Ratio of -0.43x as of December 2025, meaning its operating cash flow of $-30.94 Million could theoretically repay 0% of its total liabilities ($72.76 Million) in one year. See how liquid is Zentalis Pharmaceuticals Llc's working capital to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zentalis Pharmaceuticals Llc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Zentalis Pharmaceuticals Llc across 8 annual periods. Also explore ZNTL shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zentalis Pharmaceuticals Llc (2018–2025)
Year-by-year debt coverage analysis for Zentalis Pharmaceuticals Llc. For market capitalisation and broader financial context, see Zentalis Pharmaceuticals Llc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.72x | $-125.25 Million | $72.76 Million | ▲ +6.2% |
| 2024 | -1.83x | $-170.86 Million | $93.15 Million | ▼ -10.0% |
| 2023 | -1.67x | $-207.82 Million | $124.64 Million | ▼ -21.6% |
| 2022 | -1.37x | $-163.75 Million | $119.43 Million | ▲ +4.3% |
| 2021 | -1.43x | $-154.09 Million | $107.54 Million | ▲ +46.9% |
| 2020 | -2.70x | $-86.83 Million | $32.18 Million | ▼ -36.6% |
| 2019 | -1.98x | $-39.14 Million | $19.81 Million | ▲ +29.2% |
| 2018 | -2.79x | $-24.25 Million | $8.69 Million | — |